India-based Nexstem, creates Brain-Computer Interface (BCI) solutions has secured USD 3.5 Million in its latest funding round.
Read also – Mush Social Raises $1.2 Mn Funding in Pre-Seed Round
The funding round was supported by prominent investors such as InfoEdge, Zupee, Smile Group, and Gruhas, which was founded by Nikhil Kamath and Abhijeet Pai.
Read also – Warburg AI Raises $250k Seed Funding
This investment will enable Nexstem to scale its breakthrough product ecosystem and expand its intellectual property (IP) portfolio, positioning the company to disrupt the rapidly expanding neurotech sector. The funding will also help the company expand globally, particularly into the US and European markets.
“We believe that BCI would emerge as an extremely transformative technology in the next decade or so and we are very excited to back the Nexstem team in their endeavour in this space. In an industry characterised by lengthy development cycles and substantial investment, Nexstem’s progress has been fast, frugal and exceptional,” said Vibhore Sharma, Tech Investments, InfoEdge.
“Our focus is on harnessing complex biosignal data from the human body, which will help us create better products, and highly customised services and understand humans better than ever. By addressing these challenges, we are opening doors to applications once imagined in sci-fi, such as longevity and telepathy,” said Siddhant Dangi, Co-founder, Nexstem. He added, “Our approach as an early platform player enables us to help others realise impactful use cases in neurotechnology, carefully balancing innovation with practical applications.”
About Nexstem
Siddhant Dangi and Deepansh Goyal in 2020 Nexstem’s technology is recognized by many stalwarts of the industries includes Mircrosoft for Startups, NASSCOM, VIVA tech Paris, YourStory, and many more.
